Published On: Sep 16, 2020

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund has tied up with India's Dr Reddy’s Laboratories to conduct the clinical trials and distribution of Sputnik V vaccine in India. ET’s Divya Rajagopal caught up with CEO RDIF, Kirill Dmitriev to understand when the vaccine will be available in India. Watch  

Related Videos

Entertainment Articles